BIZ NEWS: Is This Under-the-Radar Biotech Stock a Buy Near an All-Time High? - BUSINESS DAILY

Hot

Post Top Ad

Your Ad Spot

Monday, 25 March 2019

BIZ NEWS: Is This Under-the-Radar Biotech Stock a Buy Near an All-Time High?


Is This Under-the-Radar Biotech Stock a Buy Near an All-Time High?



Repligen has grown product revenue 220% since 2014, but it trades at 70 times future earnings. What should investors make of that?

via FOX BUSINESS NEWS https://ift.tt/2HOE1cO

No comments:

Post a Comment

Post Top Ad